FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4248408043> ?p ?o ?g. }

• W4248408043 endingPage "332" @default.
• W4248408043 startingPage "332" @default.
• W4248408043 abstract "Dyrenium® (triamterene, GlaxoSmithKline) is a potassium-sparing diuretic used in the treatment of edema associated with congestive heart failure, liver cirrhosis, nephrotic syndrome, and use of steroids or secondary hyperaldosteronism. The drug is also used in combination with other diuretics in the treatment of hypokalemia and hypertension. Triamterene inhibits the reabsorption of sodium in exchange for potassium and hydrogen in the distal tubule. The action of the drug is under the control of mineralocorticoid (aldosterone) activity. The more sodium reaching the distal tubule, the stronger the diuretic effect and potassium conservation. After oral administration, the drug is rapidly absorbed. The onset of action is in 2–4 hours, and peak effect occurs after several days of therapy. The duration of action is 7–9 hours. 80% of the drug is metabolized in the liver and 50% is excreted in the urine. The plasma half-life is 1.5–2.5 hours. The drug is contraindicated in patients with anuria or severe, progressive renal disease and diabetic nephropathy. It should not be given to patients with severe hepatic dysfunction. It should not be used in patients with elevated potassium levels or patients already taking another potassium-sparing diuretic. During triamterene administration, blood pressure, urine output, weight, and serum electrolytes should be monitored. Arrhythmias, orthostatic hypotension, and angina are the most common adverse cardiac reactions. Dehydration, fatigue, muscle cramps, nausea, and diarrhea are other reported adverse effects. The drug should not be used with other potassium-sparing diuretics, such as spironolactone and amiloride. Care must be taken when the drug is administered with other potassium-sparing agents, such as angiotensin-converting enzyme inhibitors and angiotensin II receptor-blocking agents. Drug interactions have been reported with lithium, nonsteroidal anti-inflammatory agents, and cardiac glycosides. Triamterene can raise blood glucose levels in patients with adult-onset diabetes mellitus. Concomitant use of the drug with chlorpropamide can increase the risk of hyponatremia. The drug can be used in pregnancy if clearly indicated; it is not recommended during breast feeding. The usual starting dose is 100 mg/b.i.d. after meals. The daily dosage should not exceed 300 mg. Once symptoms of edema are controlled, the dosage can be reduced to administration every other day or to 50 mg/day. When triamterene is used in combination with other kaluretic diuretics, the initial dosage is 25 mg/day, with increases as needed to a maximum dose of 100 mg/day. Dyrenium® is a familiar potassium-sparing diuretic used in the treatment of symptomatic edema of various etiologies. The drug can also be used in combination with other diuretics in the treatment of hypertension. Monitoring of electrolytes is important to ensure its safe use." @default.
• W4248408043 created "2022-05-12" @default.
• W4248408043 creator A5015115400 @default.
• W4248408043 date "2001-09-01" @default.
• W4248408043 modified "2023-09-27" @default.
• W4248408043 title "New Therapy Update" @default.
• W4248408043 doi "https://doi.org/10.1111/j.1524-6175.2001.00481.x" @default.
• W4248408043 hasPublicationYear "2001" @default.
• W4248408043 type Work @default.
• W4248408043 citedByCount "0" @default.
• W4248408043 crossrefType "journal-article" @default.
• W4248408043 hasAuthorship W4248408043A5015115400 @default.
• W4248408043 hasBestOaLocation W42484080431 @default.
• W4248408043 hasConcept C126322002 @default.
• W4248408043 hasConcept C126894567 @default.
• W4248408043 hasConcept C134018914 @default.
• W4248408043 hasConcept C178790620 @default.
• W4248408043 hasConcept C185592680 @default.
• W4248408043 hasConcept C198710026 @default.
• W4248408043 hasConcept C2776138174 @default.
• W4248408043 hasConcept C2776379505 @default.
• W4248408043 hasConcept C2777622974 @default.
• W4248408043 hasConcept C2778198053 @default.
• W4248408043 hasConcept C2778242168 @default.
• W4248408043 hasConcept C2778525890 @default.
• W4248408043 hasConcept C2779608910 @default.
• W4248408043 hasConcept C2779918671 @default.
• W4248408043 hasConcept C2780243291 @default.
• W4248408043 hasConcept C2780361556 @default.
• W4248408043 hasConcept C537181965 @default.
• W4248408043 hasConcept C71924100 @default.
• W4248408043 hasConcept C84393581 @default.
• W4248408043 hasConcept C98274493 @default.
• W4248408043 hasConceptScore W4248408043C126322002 @default.
• W4248408043 hasConceptScore W4248408043C126894567 @default.
• W4248408043 hasConceptScore W4248408043C134018914 @default.
• W4248408043 hasConceptScore W4248408043C178790620 @default.
• W4248408043 hasConceptScore W4248408043C185592680 @default.
• W4248408043 hasConceptScore W4248408043C198710026 @default.
• W4248408043 hasConceptScore W4248408043C2776138174 @default.
• W4248408043 hasConceptScore W4248408043C2776379505 @default.
• W4248408043 hasConceptScore W4248408043C2777622974 @default.
• W4248408043 hasConceptScore W4248408043C2778198053 @default.
• W4248408043 hasConceptScore W4248408043C2778242168 @default.
• W4248408043 hasConceptScore W4248408043C2778525890 @default.
• W4248408043 hasConceptScore W4248408043C2779608910 @default.
• W4248408043 hasConceptScore W4248408043C2779918671 @default.
• W4248408043 hasConceptScore W4248408043C2780243291 @default.
• W4248408043 hasConceptScore W4248408043C2780361556 @default.
• W4248408043 hasConceptScore W4248408043C537181965 @default.
• W4248408043 hasConceptScore W4248408043C71924100 @default.
• W4248408043 hasConceptScore W4248408043C84393581 @default.
• W4248408043 hasConceptScore W4248408043C98274493 @default.
• W4248408043 hasIssue "5" @default.
• W4248408043 hasLocation W42484080431 @default.
• W4248408043 hasLocation W42484080432 @default.
• W4248408043 hasOpenAccess W4248408043 @default.
• W4248408043 hasPrimaryLocation W42484080431 @default.
• W4248408043 hasRelatedWork W129897216 @default.
• W4248408043 hasRelatedWork W1966126362 @default.
• W4248408043 hasRelatedWork W1999646761 @default.
• W4248408043 hasRelatedWork W2064699047 @default.
• W4248408043 hasRelatedWork W2066430973 @default.
• W4248408043 hasRelatedWork W2080434175 @default.
• W4248408043 hasRelatedWork W2082256004 @default.
• W4248408043 hasRelatedWork W2117128694 @default.
• W4248408043 hasRelatedWork W2124087925 @default.
• W4248408043 hasRelatedWork W44831689 @default.
• W4248408043 hasVolume "3" @default.
• W4248408043 isParatext "false" @default.
• W4248408043 isRetracted "false" @default.
• W4248408043 workType "article" @default.